Anzeige
Mehr »
Login
Sonntag, 13.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Eine weltweite Kupferknappheit zeichnet sich ab: Warum Gladiator Metals (WKN: A3D6HK) die Antwort sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
185 Leser
Artikel bewerten:
(1)

Over The Counter (OTC) Drugs Market is expected to generate a revenue of USD 367.08 Billion by 2031, Globally, at 8.10% CAGR: Verified Market Research

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the "Over The Counter (OTC) Drugs Market Size and Forecast". This comprehensive report provides an in-depth analysis of the industry's current landscape, growth potential, and key trends, offering valuable insights for industry leaders and decision-makers.

LEWES, Del., Oct. 8, 2024 /PRNewswire/ -- The Global Over The Counter (OTC) Drugs Market Size is projected to grow at a CAGR of 8.10% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 196.86 Billion in 2024 and is expected to reach USD 367.08 Billion by the end of the forecast period.

Verified Market Research Logo

The OTC drugs market is undergoing significant expansion, driven by increased consumer demand for self-medication, easier access to pharmaceuticals, and growing awareness of personal health. The report offers a detailed examination of market drivers, such as shifting consumer behavior, regulatory updates, and the influence of e-commerce on OTC drug sales.

Key Insights of the Report Include:

  • Market Size & Forecast: A thorough analysis of the current market size, with projections indicating robust growth over the next five years
  • Competitive Landscape: Detailed profiles of top industry players, including their market strategies, product portfolios, and investment trends
  • Regional Insights: Market breakdown by region, identifying high-growth opportunities in North America, Europe, Asia-Pacific, and other key regions
  • Trends & Innovations: Emerging trends in product formulations, packaging, and digital health technologies driving consumer preferences

Why This Report Matters for Industry leaders:

This report is essential for pharmaceutical manufacturers, retailers, healthcare providers, and regulatory authorities looking to capitalize on the expanding OTC drugs market. With a surge in demand for pain relievers, vitamins, minerals, and topical treatments, industry players must be equipped with data-driven strategies to stay ahead of the competition.

Stay ahead of the curve in the ever-evolving Over The Counter (OTC) Drugs Market. For more information or to request a sample copy of the report, please visit: https://www.verifiedmarketresearch.com/download-sample?rid=144745

Browse in-depth TOC on "Global Over The Counter (OTC) Drugs Market Size"

202 - Pages
126 - Tables
37 - Figures

Report Scope

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2021-2031

GROWTH RATE

CAGR of ~8.10% from 2024 to 2031

BASE YEAR FOR VALUATION

2024

HISTORICAL PERIOD

2021-2023

FORECAST PERIOD

2024-2031

QUANTITATIVE UNITS

Value in USD Billion

REPORT COVERAGE

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

SEGMENTS COVERED

  • Product Type
  • Distribution Channel
  • Formulation Type

REGIONS COVERED

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

KEY PLAYERS

Johnson & Johnson Private Limited (U.S.), Reddy's Laboratories Ltd. (India), Reckitt Benckiser Group PLC (U.K.), Takeda Pharmaceutical Company Limited (Japan), Sanofi (France), Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Alkem Labs (India), Cipla Inc. (India)

CUSTOMIZATION

Report customization along with purchase available upon request

Global Over The Counter (OTC) Drugs Market Overview

Rise in Self-Medication and Consumer Awareness: The rising prevalence of self-medication, driven by heightened health awareness, is stimulating expansion in the Over The Counter (OTC) Drugs Market. Consumers favor convenient access to treatment for prevalent conditions without a prescription, resulting in an increased demand for over-the-counter treatments. This transition enables firms to launch new product lines, enhancing revenue streams and fostering chances for innovation in formulation and delivery techniques.

Expanding E-Commerce and Digital Health Platforms: The emergence of e-commerce and digital health platforms has revolutionized consumer access to OTC medications, broadening market availability worldwide. The ease of online shopping and home delivery, along with virtual health consultations, enhances the accessibility of OTC products, particularly in underprivileged areas. This factor is anticipated to catalyze substantial expansion in the Over The Counter (OTC) Drugs Market, prompting enterprises to enhance their digital presence and collaborations.

Regulatory Support for OTC Product Approvals: Supportive regulatory measures are streamlining the approval procedure for new OTC medications, facilitating expedited market entrance. Governments around are advocating for the utilization of OTC products to alleviate the strain on healthcare systems. This factor propels innovation and competition in the Over The Counter (OTC) Drugs Market, providing chances for enterprises to introduce new therapeutic categories, hence fostering market expansion and consumer confidence.

To Purchase a Comprehensive Report Analysis: https://www.verifiedmarketresearch.com/select-licence?rid=144745

Risk of Misuse and Adverse Reactions: A primary constraint in the Over The Counter (OTC) Drugs Market is the potential for consumer misuse or overconsumption stemming from the accessibility of OTC medications. Improper use without adequate medical supervision might result in negative effects, diminishing consumer confidence and prompting more stringent regulations. Companies must confront this challenge by improving product labeling and consumer education to protect market growth and uphold reputation.

Intense Competition from Generic Drugs: The abundance of inexpensive generic alternatives in the Over The Counter (OTC) Drugs Market exerts pricing pressure, constraining profit margins for branded OTC medicine producers. Fierce competition in the generic sector may hinder market expansion, compelling companies to concentrate on differentiation techniques, including enhanced formulations, brand loyalty, and superior marketing initiatives to sustain a competitive advantage.

Stringent Regulations on Advertising and Labeling: Strict regulations regarding the advertising and labeling of OTC pharmaceuticals may restrict promotional efforts and product visibility, especially in areas with stringent health communication laws. This limitation hinders market expansion as enterprises encounter difficulties in accessing new consumers and markets. To address this, enterprises in the Over The Counter (OTC) Drugs Market must formulate compliant yet persuasive marketing tactics to improve product visibility.

Geographical Dominance

North America exhibits substantial geographical preeminence in the Over The Counter (OTC) Drugs Market, propelled by elevated consumer demand for self-care goods, a robust healthcare infrastructure, and advantageous regulatory backing. This dominance influences market expansion by fostering innovation and investment in new product development, while simultaneously establishing industry norms. The region's dominance in digital health platforms enhances OTC medicine accessibility, promoting market growth and global competitive advantage.

Key Players

The "Global Over The Counter (OTC) Drugs Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson Private Limited (U.S.), Reddy's Laboratories Ltd. (India), Reckitt Benckiser Group PLC (U.K.), Takeda Pharmaceutical Company Limited (Japan), Sanofi (France), Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Alkem Labs (India), Cipla Inc. (India).

Over The Counter (OTC) Drugs Market Segment Analysis

Based on the research, Verified Market Research has segmented the global Over The Counter (OTC) Drugs Market into Product Type, Distribution Channel, Formulation Type and Geography.

  • Over The Counter (OTC) Drugs Market, by Product Type:
    • Analgesics
    • Cold, cough & flu products
    • Dermatological products
    • Mineral and vitamin supplements
  • Over The Counter (OTC) Drugs Market, by Distribution Channel:
    • Pharmacies
    • Supermarkets/Hypermarkets
    • Convenience stores
  • Over The Counter (OTC) Drugs Market, by Formulation Type:
    • Tablets
    • Liquids
    • Ointments
    • Sprays
  • Over The Counter (OTC) Drugs Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Global Cold And Flu Drugs Market Size By Type (Antihistamines, Decongestants), By Application (Prescription Medications, Over-the-Counter (OTC) Medications), By End User (Hospitals and Clinics, Retail Pharmacies), By Geography, And Forecast

Global Injectable Drug Delivery Devices Market Size By Product Type (Conventional Injection Devices, Self-injection Devices), Application (Autoimmune Diseases, Oncology), Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores), By Geography, And Forecast

Global Gene Expression Market Size By Technology (Microarrays, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), By Product (DNA, Kits & Reagents), By Application (Drug Discovery and Development, Clinical Diagnostics, Biotech and Microbiology), By Geography, And Forecast

Global Automated Analyzers Market Size By Product (Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers), By Application (Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics), By Geography, And Forecast

Top 10 Ophthalmic Drugs Manufacturers bringing confidence with a better sight

Visualize Over The Counter (OTC) Drugs Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.

With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.

VMR's domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.

Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR's dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/over-the-counter-otc-drugs-market-is-expected-to-generate-a-revenue-of-usd-367-08-billion-by-2031--globally-at-8-10-cagr-verified-market-research-302270039.html

© 2024 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.